Once-yearly zoledronic acid in hip fracture prevention
Oddom Demontiero, Gustavo DuqueAging Bone Research Program, Nepean Clinical School, University of Sydney, Penrith, NSW, Australia; Department of Geriatric Medicine, Nepean Hospital, Penrith, NSW, AustraliaAbstract: Osteoporosis is an escalating global problem. Hip fractures, the most catastrophic co...
Enregistré dans:
Auteurs principaux: | Oddom Demontiero, Gustavo Duque |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Dove Medical Press
2009
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/a9df2c8fdb1b4560859e08926227e858 |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Role of zoledronic acid in the prevention and treatment of osteoporosis
par: Räkel A, et autres
Publié: (2011) -
Percutaneous kyphoplasty combined with zoledronic acid infusion in the treatment of osteoporotic thoracolumbar fractures in the elderly
par: Shi C, et autres
Publié: (2018) -
Management of osteoporosis in the aging male: Focus on zoledronic acid
par: Paul K Piper Jr, et autres
Publié: (2009) -
Reducing hip fracture risk with risedronate in elderly women with established osteoporosis
par: Tahir Masud, et autres
Publié: (2009) -
Bisphosphonate use and hip fracture epidemiology: ecologic proof from the contrary
par: Alex Fisher, et autres
Publié: (2010)